MetLife Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$225K Hold
11,994
﹤0.01% 2129
2025
Q1
$216K Sell
11,994
-264
-2% -$4.75K ﹤0.01% 2158
2024
Q4
$206K Buy
12,258
+2,014
+20% +$33.9K ﹤0.01% 2288
2024
Q3
$166K Sell
10,244
-1
-0% -$16 ﹤0.01% 2380
2024
Q2
$84.2K Buy
10,245
+3,003
+41% +$24.7K ﹤0.01% 2673
2024
Q1
$107K Sell
7,242
-2,030
-22% -$30K ﹤0.01% 2501
2023
Q4
$134K Hold
9,272
﹤0.01% 2459
2023
Q3
$100K Hold
9,272
﹤0.01% 2574
2023
Q2
$120K Hold
9,272
﹤0.01% 2578
2023
Q1
$122K Buy
9,272
+2,791
+43% +$36.8K ﹤0.01% 2468
2022
Q4
$97.2K Sell
6,481
-3,055
-32% -$45.8K ﹤0.01% 2602
2022
Q3
$113K Buy
9,536
+8,764
+1,135% +$103K ﹤0.01% 2626
2022
Q2
$8.72K Sell
772
-7,799
-91% -$88.1K ﹤0.01% 2852
2022
Q1
$256K Buy
8,571
+5,613
+190% +$168K ﹤0.01% 2199
2021
Q4
$78.4K Sell
2,958
-3,199
-52% -$84.8K ﹤0.01% 2454
2021
Q3
$223K Buy
6,157
+1,987
+48% +$72.1K ﹤0.01% 2018
2021
Q2
$181K Sell
4,170
-2,763
-40% -$120K ﹤0.01% 2228
2021
Q1
$237K Buy
6,933
+2,155
+45% +$73.7K ﹤0.01% 1964
2020
Q4
$167K Buy
4,778
+69
+1% +$2.42K ﹤0.01% 2078
2020
Q3
$113K Sell
4,709
-3,390
-42% -$81.4K ﹤0.01% 2163
2020
Q2
$148K Buy
8,099
+4,124
+104% +$75.5K ﹤0.01% 2062
2020
Q1
$62K Sell
3,975
-4,359
-52% -$68K ﹤0.01% 2220
2019
Q4
$178K Buy
8,334
+6,948
+501% +$149K ﹤0.01% 2040
2019
Q3
$25.9K Sell
1,386
-9,335
-87% -$175K ﹤0.01% 2326
2019
Q2
$280K Buy
10,721
+3,906
+57% +$102K ﹤0.01% 1832
2019
Q1
$175K Hold
6,815
﹤0.01% 2042
2018
Q4
$157K Hold
6,815
﹤0.01% 2044
2018
Q3
$219K Sell
6,815
-3,321
-33% -$107K ﹤0.01% 2031
2018
Q2
$287K Buy
10,136
+3,509
+53% +$99.4K ﹤0.01% 1736
2018
Q1
$235K Hold
6,627
﹤0.01% 1803
2017
Q4
$257K Buy
+6,627
New +$257K ﹤0.01% 1793